[Antiblastic therapy and cytolysis in infantile leukemia].
D000493:Allopurinol / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001002:Anuria / Q000209:etiology; D001639:Bicarbonates / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004211:Disseminated Intravascular Coagulation / Q000209:etiology; D004573:Electrolytes / Q000627:therapeutic use; D006801:Humans; D007674:Kidney Diseases / Q000209:etiology; D007938:Leukemia / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D009696:Nucleic Acids / Q000378:metabolism; D011241:Prednisone / Q000627:therapeutic use; D011687:Purines / Q000378:metabolism; D014527:Uric Acid / Q000097:blood; D014750:Vincristine / Q000627:therapeutic use; D014970:Xanthines / Q000378:metabolism
D000970:Antineoplastic Agents; D001639:Bicarbonates; D004573:Electrolytes; D009696:Nucleic Acids; D011687:Purines; D014970:Xanthines; D014527:Uric Acid; D014750:Vincristine; D000493:Allopurinol; D011241:Prednisone
Terapia antiblastica e citolisi nella leucemia infantile